Neil Chatterji
Stock Analyst at B. Riley Securities
(1.45)
# 3,552
Out of 5,156 analysts
20
Total ratings
27.78%
Success rate
0.55%
Average return
Main Sectors:
Stocks Rated by Neil Chatterji
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLPT ClearPoint Neuro | Maintains: Buy | $28 → $18 | $11.54 | +55.98% | 5 | Mar 5, 2026 | |
| OPRX OptimizeRx | Maintains: Buy | $17 → $13 | $6.84 | +90.06% | 3 | Dec 24, 2024 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $95 → $50 | $69.06 | -27.60% | 2 | Nov 9, 2023 | |
| ARAY Accuray | Reiterates: Buy | $7.5 | $0.49 | +1,428.74% | 1 | Oct 4, 2023 | |
| ZUMZ Zumiez | Maintains: Neutral | $15 → $18 | $23.28 | -22.68% | 2 | Sep 8, 2023 | |
| KRMD KORU Medical Systems | Initiates: Buy | $4.5 | $4.61 | -2.39% | 1 | Sep 7, 2023 | |
| HYPR Hyperfine | Maintains: Buy | $2.5 → $3.5 | $1.16 | +201.72% | 3 | Aug 15, 2023 | |
| STXS Stereotaxis | Maintains: Buy | $6 → $5.5 | $2.07 | +165.70% | 2 | Mar 6, 2023 | |
| BFLY Butterfly Network | Initiates: Buy | $9.5 | $3.76 | +152.66% | 1 | Oct 4, 2022 |
ClearPoint Neuro
Mar 5, 2026
Maintains: Buy
Price Target: $28 → $18
Current: $11.54
Upside: +55.98%
OptimizeRx
Dec 24, 2024
Maintains: Buy
Price Target: $17 → $13
Current: $6.84
Upside: +90.06%
Establishment Labs Holdings
Nov 9, 2023
Maintains: Buy
Price Target: $95 → $50
Current: $69.06
Upside: -27.60%
Accuray
Oct 4, 2023
Reiterates: Buy
Price Target: $7.5
Current: $0.49
Upside: +1,428.74%
Zumiez
Sep 8, 2023
Maintains: Neutral
Price Target: $15 → $18
Current: $23.28
Upside: -22.68%
KORU Medical Systems
Sep 7, 2023
Initiates: Buy
Price Target: $4.5
Current: $4.61
Upside: -2.39%
Hyperfine
Aug 15, 2023
Maintains: Buy
Price Target: $2.5 → $3.5
Current: $1.16
Upside: +201.72%
Stereotaxis
Mar 6, 2023
Maintains: Buy
Price Target: $6 → $5.5
Current: $2.07
Upside: +165.70%
Butterfly Network
Oct 4, 2022
Initiates: Buy
Price Target: $9.5
Current: $3.76
Upside: +152.66%